(Total Views: 137)
Posted On: 02/15/2022 9:54:57 AM
Post# of 43038
Avalon GloboCare Corp (NASDAQ: $AVCO) is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-NK) cell therapies. https://finance.yahoo.com/news/avalon-globoca...21173.html
(0)
(0)
Scroll down for more posts ▼
